These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8212980)

  • 1. Drugs recently released in Belgium. Cefpodoxime proxetil--Fosinopril.
    Harvengt C
    Acta Clin Belg; 1993; 48(4):284-7. PubMed ID: 8212980
    [No Abstract]   [Full Text] [Related]  

  • 2. [Reevaluation of current antimicrobials. Cefpodoxime proxetil. Discussion].
    Jpn J Antibiot; 1995 Feb; 48(2):183-90. PubMed ID: 7745807
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical evaluation of cefpodoxime proxetil on the treatment of bacterial infections].
    Li JT; Hou J; Kao L
    Zhonghua Nei Ke Za Zhi; 1994 Jul; 33(7):440-3. PubMed ID: 7867436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefpodoxime proxetil--a new oral cephalosporin.
    Med Lett Drugs Ther; 1992 Nov; 34(884):107-8. PubMed ID: 1435506
    [No Abstract]   [Full Text] [Related]  

  • 5. Review of clinical experience in the United States with cefpodoxime proxetil in adults with uncomplicated urinary tract infections.
    Cox CE; Graveline JF; Luongo JM
    Drugs; 1991; 42 Suppl 3():41-50. PubMed ID: 1726207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of cefpodoxime proxetil with cefaclor in the treatment of sinusitis.
    Gehanno P; Depondt J; Barry B; Simonet M; Dewever H
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():87-91. PubMed ID: 2127269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Respiratory tract infections in general practice. Cefpodoxime proxetil in patients with risk factors and concomitant illnesses].
    Kardos P; Wiese K
    MMW Fortschr Med; 2000 Feb; 142(5):41. PubMed ID: 10715939
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and tolerance of cefpodoxime proxetil compared with ceftriaxone in vulnerable patients with bronchopneumonia.
    Zuck P; Rio Y; Ichou F
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():71-7. PubMed ID: 2292534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of cefpodoxime proxetil dry syrup in pediatric patients with various infections.
    Muranaka H; Yokoyama M
    J Chemother; 1995 Nov; 7 Suppl 4():127-30. PubMed ID: 8904132
    [No Abstract]   [Full Text] [Related]  

  • 10. A multi-institutional study on clinical effectiveness of cefpodoxime proxetil dry syrup in childhood infections.
    Imanaka H; Kitahara T; Yoshinaga M; Miyata K
    J Chemother; 1995 Nov; 7 Suppl 4():131-3. PubMed ID: 8904133
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical evaluation of cefpodoxime proxetil dry syrup in pediatric cutaneous bacterial infection.
    Terui T; Tagami H
    J Chemother; 1995 Nov; 7 Suppl 4():119-21. PubMed ID: 8904129
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical evaluation of cefpodoxime proxetil in patients with dermatological infections.
    Imaizumi T; Ishikawa H; Hashimoto I
    J Chemother; 1995 Nov; 7 Suppl 4():137-41. PubMed ID: 8904135
    [No Abstract]   [Full Text] [Related]  

  • 13. Bioavailability of cefpodoxime proxetil with co-administered acetylcysteine.
    Kees F; Wellenhofer M; Bröhl K; Grobecker H
    Arzneimittelforschung; 1996 Apr; 46(4):435-8. PubMed ID: 8740095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiological and clinical studies on cefpodoxime proxetil for bacterial skin and soft tissue infections in pediatric patients.
    Ito K; Ito M
    J Chemother; 1995 Nov; 7 Suppl 4():124-6. PubMed ID: 8904131
    [No Abstract]   [Full Text] [Related]  

  • 15. Cefpodoxime proxetil: dosage, efficacy and tolerance in adults suffering from respiratory tract infections.
    Safran C
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():93-101. PubMed ID: 2292535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of cefpodoxime proxetil and cefaclor in the treatment of acute exacerbation of COPD in adults.
    Phillips H; Van Hook CJ; Butler T; Todd WM
    Chest; 1993 Nov; 104(5):1387-92. PubMed ID: 8222793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Summary of clinical experience with cefpodoxime proxetil in adults in Japan.
    Kumazawa J
    Drugs; 1991; 42 Suppl 3():1-5. PubMed ID: 1726202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic study and clinical evaluation of cefpodoxime proxetil in the elderly with impaired renal function.
    Ishioka T
    J Chemother; 1995 Nov; 7 Suppl 4():122-3. PubMed ID: 8904130
    [No Abstract]   [Full Text] [Related]  

  • 19. Cefpodoxime proxetil for infective exacerbations of chronic obstructive airway disease.
    Alderman CP
    Ann Pharmacother; 1996 Feb; 30(2):196. PubMed ID: 8835062
    [No Abstract]   [Full Text] [Related]  

  • 20. Cefpodoxime proxetil in the treatment of skin and soft tissue infections.
    Tack KJ; Wilks NE; Semerdjian G; Frazier CH; Shirin K; Puopolo A; Crossland SG; Goffe BS; Millikan L
    Drugs; 1991; 42 Suppl 3():51-6. PubMed ID: 1726208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.